Company Description
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples, all through a single puncture site.
The company also offers interventional products, which consists of various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments.
The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, and Deknatel and HPC Medical brands.
It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
| Country | United States |
| Founded | 1943 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 14,100 |
| CEO | Liam Kelly |
Contact Details
Address: 550 East Swedesford Road, Suite 400 Wayne, Pennsylvania 19087-1603 United States | |
| Phone | 610-225-6800 |
| Website | teleflex.com |
Stock Details
| Ticker Symbol | TFX |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000096943 |
| CUSIP Number | 879369106 |
| ISIN Number | US8793691069 |
| Employer ID | 23-1147939 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Liam J. Kelly | Chairman, President and Chief Executive Officer |
| Thomas E. Powell BS, MBA | Executive Vice President and Chief Financial Officer |
| Daniel V. Logue J.D. | Corporate Vice President, General Counsel and Secretary |
| Jay White | Corporate Vice President and President of Global Commercial |
| John R. Deren | Corporate Vice President and Chief Accounting Officer |
| Timothy F. Duffy | Vice President and Chief Information Officer |
| Howard Cyr | Corporate Vice President and Chief Compliance Officer |
| Cameron P. Hicks | Corporate Vice President and Chief Human Resources Officer |
| James Ferguson | President and GM of Surgical |
| Michelle Fox | Corporate Vice President and Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 4, 2025 | 8-K | Current Report |
| Feb 28, 2025 | 10-K | Annual Report |
| Feb 27, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 5, 2025 | SCHEDULE 13G/A | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 31, 2024 | 10-Q | Quarterly Report |